BlackRock Fund Advisors’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | $14.4M | Buy |
105,751
+11,229
| +12% | +$1.53M | ﹤0.01% | 2367 |
|
2016
Q3 | $18.8M | Buy |
94,522
+6,202
| +7% | +$1.23M | ﹤0.01% | 2101 |
|
2016
Q2 | $11.4M | Buy |
88,320
+32,539
| +58% | +$4.22M | ﹤0.01% | 2326 |
|
2016
Q1 | $5.22M | Buy |
55,781
+2,252
| +4% | +$211K | ﹤0.01% | 2723 |
|
2015
Q4 | $10.9M | Buy |
53,529
+31,375
| +142% | +$6.36M | ﹤0.01% | 2400 |
|
2015
Q3 | $3.22M | Buy |
22,154
+65
| +0.3% | +$9.45K | ﹤0.01% | 2992 |
|
2015
Q2 | $4.7M | Sell |
22,089
-1,311
| -6% | -$279K | ﹤0.01% | 2960 |
|
2015
Q1 | $5.42M | Buy |
+23,400
| New | +$5.42M | ﹤0.01% | 2803 |
|